PAND
Pandion Therapeutics Inc

195
Mkt Cap
$1.77B
Volume
241,584.00
52W High
$62.90
52W Low
$10.28
PE Ratio
-39.69
PAND Fundamentals
Price
$60.05
Prev Close
$59.92
Open
$59.95
50D MA
$40.85
Beta
-0.51
Avg. Volume
275,413.35
P/B
7.94
Loading...
Loading...

About

Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Pandion Therapeutics Inc?
What is the 52-week high for Pandion Therapeutics Inc?
What is the 52-week low for Pandion Therapeutics Inc?
What is Pandion Therapeutics Inc stock price today?
What was Pandion Therapeutics Inc stock price yesterday?
What is the PE ratio of Pandion Therapeutics Inc?
What is the Price-to-Book ratio of Pandion Therapeutics Inc?
What is the 50-day moving average of Pandion Therapeutics Inc?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available

Latest PAND News

View
No PAND news at the moment.
Top Discussions

Advertisement|Remove ads.